NFKB1 and breast cancer: Because increased NF-kB activity was claimed to be responsible for the resistance to death ligand induced cytotoxicity in some tumors [36,37], we wanted to test if the inhibition of IKK activity thereby NF-kB would reduce the viability of breast cancer cells.